Summary
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Molecular Biomarkers for Cancer Detection and Management , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Molecular Biomarkers for Cancer Detection and Management market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
Asia-Pacific (China, India, Japan, Southeast Asia etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)
By Type
Screening, Detection, Risk Assessment, and Monitoring Biomarkers
Prognosis and Prediction Biomarkers
Companion Diagnostic Biomarkers
By End-User / Application
Hospital
Research Institutions
Others
By Company
Alere
Atossa Genetics
Biophysical
Abbott
BioCept
BioTheranostics
DiagnoCure
GenomeDx
Genomic Health
Gen-Probe
Life Technologies
20/20 GeneSystems
Cynvenio
Dako (Agilent)
Epic Sciences
Foundation Medicine
Genomic Health
Molecular Response
Nodality
PGD
Table of Contents
Part 1 Market Definition
1.1 Market Segment Overview
Figure Global Molecular Biomarkers for Cancer Detection and Management Market Size (Million USD) 2017-2025
1.2 by Type
Table Global Molecular Biomarkers for Cancer Detection and Management Market and Growth by Type
1.3 by End-Use / Application
Table Global Molecular Biomarkers for Cancer Detection and Management Market and Growth by End-Use / Application
2 Global Market by Vendors
2.1 Market Share
Table Global Molecular Biomarkers for Cancer Detection and Management Revenue (Million USD) by Vendors (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Revenue Share by Vendors (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) by Vendors (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume Share by Vendors (2017-2019)
2.2 Vendor Profile
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
2.3 Dynamic of Vendors
3 Global Market by Type
3.1 Market Share
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) by Type (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume Share by Type (2017-2019)
3.2 Introduction of End-Use by Different Products
4 Global Market by End-Use / Application
4.1 Market Share
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume Share by End-Use / Application (2017-2019)
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 Global Market by Regions
5.1 Market Share
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) by Regions (2017-2019)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume Share by Regions (2017-2019)
5.2 Regional Market Growth
5.2.1 North America
Figure North America Market Growth 2015-2018
5.2.2 Europe
Figure Europe Market Growth 2017-2019
5.2.3 Asia-Pacific
Figure Asia-Pacific Market Growth 2017-2019
5.2.4 South America
Figure South America Market Growth 2017-2019
5.2.5 Middle East & Africa
Figure Middle East & Africa Market Growth 2017-2019
6 North America Market
6.1 by Type
Table North America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table North America Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
6.2 by End-Use / Application
Table North America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table North America Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
6.3 by Regions
Table North America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table North America Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
7 Europe Market
7.1 by Type
Table Europe Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table Europe Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
7.2 by End-Use / Application
Table Europe Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
7.3 by Regions
Table Europe Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table Europe Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
8 Asia-Pacific Market
8.1 by Type
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
8.2 by End-Use / Application
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
8.3 by Regions
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
9 South America Market
9.1 by Type
Table South America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table South America Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
9.2 by End-Use / Application
Table South America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table South America Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
9.3 by Regions
Table South America Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
10 Middle East & Africa Market
10.1 by Type
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market Share by Type (2017-2019)
10.2 by End-Use / Application
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market Share by End-Use / Application (2017-2019)
10.3 by Regions
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Molecular Biomarkers for Cancer Detection and Management Market Share by Regions (2017-2019)
11 Market Forecast
11.1 Global Market Forecast (2020-2025)
Figure Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) and Growth Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) Forecast by Regions (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Share Forecast by Regions (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Volume Share Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) Forecast by Type (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and ManagementMarket Share by Forecast Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Molecular Biomarkers for Cancer Detection and Management Market Share Forecast by End-Use / Application (2020-2025)
12 Key Manufacturers
12.Ozark Lead Company Alere
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Table Sales Revenue, Volume, Price, Cost and Margin of Alere
12.2 Atossa Genetics
12.3 Biophysical
12.4 Abbott
12.5 BioCept
12.6 BioTheranostics
12.7 DiagnoCure
12.8 GenomeDx
12.9 Genomic Health
12.10 Gen-Probe
12.11 Life Technologies
12.12 20/20 GeneSystems
12.13 Cynvenio
12.14 Dako (Agilent)
12.15 Epic Sciences
12.16 Foundation Medicine
12.17 Genomic Health
12.18 Molecular Response
12.19 Nodality
12.20 PGD
13 Overview of Industry Development (COVID-19)
13.1 Analysis of Industry Development (COVID-19)
13.2 Industry Development Stage (COVID-19)
13.3 General Situation of Industry Development (COVID-19)
13.4 Analysis of Industry Development Characteristics (COVID-19)
14 Research Conclusion
Price : US$ 3500 |
Date : Apr 2024 |
Category : Services |
Pages : 174 |